Top 5 News Stories 7/9-7/13
1. MassBio Commends Governor, Lawmakers for Ensuring Patient Access, Physician Education
MassBio applauded Governor Patrick and the state legislature for including provisions in the Fiscal Year 2013 budget that allow Massachusetts residents to take advantage of co-payment assistance programs and ensure appropriate relationships between industry and providers.
2. Obama Signs FDA Bill Tying User Fees to Reforms
President Barack Obama Monday signed into law the bipartisan FDA bill that sailed through both chambers of Congress last month—a measure that includes a fifth five-year authorization of the Prescription Drug User Fee Act (PDUFA V), and provisions that expand the categories of drugs for which the agency will allow faster reviews and decisions.
3. Harvard and Janssen team up on deal worth up to $300M
The Harvard University lab of Douglas Melton has entered into a diabetes partnership with Johnson & Johnson subsidiary Janssen Pharmaceuticals, Inc. and German biotechnology company Evotec. It could be worth up to $300 million if an approved diabetes drug results from the deal. The deal includes an upfront payment of $8 million and proceeds will be shared between Harvard and Evotec.
4. Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals
Bristol-Myers Squibb Company commenced Tuesday, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc. Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin.
5. Mass Life Sciences Center Launches New Accelerator
The Commonwealth of Massachusetts’ quasi-public agency, the Massachusetts Life Sciences Center, has opened its 2012-2013 Accelerator Loan Program, the agency announced Monday. MLSC launched the program in 2009 as a way to help start-up businesses who need working capital or funding to pay for capital assets. A loan of up to $1 million per company is provided, an increase from the maximum amount of $750,000 offered in the past.
Posted on July 13, 2012, in MassBio, News Roundup and tagged Amylin, Bristol-Myers Squibb Co., Co-Pay Assistance, FDA, Gift Ban, Governor Deval Patrick, Harvard, Janssen, Massachusetts Life Sciences Center, PDUFA. Bookmark the permalink. Leave a Comment.